EichorEICHOR
Location: Lobos Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Lobos

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Eli Lilly and Company · NCT06338995A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT05757102A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t
Phase 2 · Research Site · AstraZeneca · NCT07525375A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · CEMLO - Centro de Especialidades Médicas Lobos - Patagones 9 · Hoffmann-La Roche · NCT05878769A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With
Phase 3 · Research Site · AstraZeneca · NCT06023589Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Con
Phase 3 · Investigational Site Number : 0320008 · Sanofi · NCT07190209
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.